Unknown

Dataset Information

0

Prevalence of anosmia and ageusia symptoms among long-term effects of COVID-19.

ABSTRACT:

SUBMITTER: Moraschini V 

PROVIDER: S-EPMC8242542 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study.
| S-EPMC8721484 | biostudies-literature
Unknown Anosmia and ageusia associated with coronavirus infection (COVID-19) - what is known?
| S-EPMC7401831 | biostudies-literature
Unknown Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms.
| S-EPMC8282876 | biostudies-literature
Unknown Long-term side effects and lingering symptoms post COVID-19 recovery.
| S-EPMC8646420 | biostudies-literature
Unknown Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: an observational study.
| S-EPMC8297994 | biostudies-literature
Unknown Anosmia but Not Ageusia as a COVID-19-Related Symptom among Cancer Patients-First Results from the PAPESCO-19 Cohort Study.
| S-EPMC8303411 | biostudies-literature
Unknown Long-term persistence of symptoms of dyspnoea in COVID-19 patients.
| S-EPMC8627107 | biostudies-literature
Unknown Asthma phenotypes, associated comorbidities, and long-term symptoms in COVID-19.
| S-EPMC8222896 | biostudies-literature
Unknown Long-term neurological manifestations of COVID-19: prevalence and predictive factors.
| S-EPMC8439956 | biostudies-literature
Genomics Human gut microbiota, COVID-19 patients with mild or severe symptoms.
2022-09-22 | E-MTAB-12236 | biostudies-arrayexpress